nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—Appetite absent—Metformin—polycystic ovary syndrome	0.0242	0.0492	CcSEcCtD
Oxycodone—Azotaemia—Metformin—polycystic ovary syndrome	0.0226	0.046	CcSEcCtD
Oxycodone—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0215	0.0437	CcSEcCtD
Oxycodone—Hypothermia—Metformin—polycystic ovary syndrome	0.0215	0.0437	CcSEcCtD
Oxycodone—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0149	0.0302	CcSEcCtD
Oxycodone—Chest discomfort—Metformin—polycystic ovary syndrome	0.0136	0.0277	CcSEcCtD
Oxycodone—Accidental injury—Metformin—polycystic ovary syndrome	0.0136	0.0277	CcSEcCtD
Oxycodone—Lightheadedness—Metformin—polycystic ovary syndrome	0.0108	0.0219	CcSEcCtD
Oxycodone—Injury—Metformin—polycystic ovary syndrome	0.00953	0.0193	CcSEcCtD
Oxycodone—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00897	0.0182	CcSEcCtD
Oxycodone—Migraine—Metformin—polycystic ovary syndrome	0.00862	0.0175	CcSEcCtD
Oxycodone—Dehydration—Metformin—polycystic ovary syndrome	0.00814	0.0165	CcSEcCtD
Oxycodone—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.008	0.0162	CcSEcCtD
Oxycodone—Breast disorder—Metformin—polycystic ovary syndrome	0.00791	0.0161	CcSEcCtD
Oxycodone—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00783	0.0159	CcSEcCtD
Oxycodone—Abdominal distension—Metformin—polycystic ovary syndrome	0.00762	0.0155	CcSEcCtD
Oxycodone—Influenza—Metformin—polycystic ovary syndrome	0.00757	0.0154	CcSEcCtD
Oxycodone—Infestation—Metformin—polycystic ovary syndrome	0.00675	0.0137	CcSEcCtD
Oxycodone—Infestation NOS—Metformin—polycystic ovary syndrome	0.00675	0.0137	CcSEcCtD
Oxycodone—Drowsiness—Metformin—polycystic ovary syndrome	0.00675	0.0137	CcSEcCtD
Oxycodone—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00638	0.013	CcSEcCtD
Oxycodone—Bradycardia—Metformin—polycystic ovary syndrome	0.00617	0.0125	CcSEcCtD
Oxycodone—Rhinitis—Metformin—polycystic ovary syndrome	0.00607	0.0123	CcSEcCtD
Oxycodone—Hepatitis—Metformin—polycystic ovary syndrome	0.00606	0.0123	CcSEcCtD
Oxycodone—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00603	0.0122	CcSEcCtD
Oxycodone—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00597	0.0121	CcSEcCtD
Oxycodone—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00595	0.0121	CcSEcCtD
Oxycodone—Eye disorder—Metformin—polycystic ovary syndrome	0.00566	0.0115	CcSEcCtD
Oxycodone—Flushing—Metformin—polycystic ovary syndrome	0.00562	0.0114	CcSEcCtD
Oxycodone—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00562	0.0114	CcSEcCtD
Oxycodone—Angiopathy—Metformin—polycystic ovary syndrome	0.0055	0.0112	CcSEcCtD
Oxycodone—Immune system disorder—Metformin—polycystic ovary syndrome	0.00547	0.0111	CcSEcCtD
Oxycodone—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00546	0.0111	CcSEcCtD
Oxycodone—Chills—Metformin—polycystic ovary syndrome	0.00544	0.011	CcSEcCtD
Oxycodone—Malnutrition—Metformin—polycystic ovary syndrome	0.00527	0.0107	CcSEcCtD
Oxycodone—Flatulence—Metformin—polycystic ovary syndrome	0.0052	0.0105	CcSEcCtD
Oxycodone—Dysgeusia—Metformin—polycystic ovary syndrome	0.00516	0.0105	CcSEcCtD
Oxycodone—Muscle spasms—Metformin—polycystic ovary syndrome	0.00507	0.0103	CcSEcCtD
Oxycodone—Tremor—Metformin—polycystic ovary syndrome	0.00494	0.01	CcSEcCtD
Oxycodone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00489	0.00993	CcSEcCtD
Oxycodone—Malaise—Metformin—polycystic ovary syndrome	0.00476	0.00965	CcSEcCtD
Oxycodone—Syncope—Metformin—polycystic ovary syndrome	0.00473	0.0096	CcSEcCtD
Oxycodone—Palpitations—Metformin—polycystic ovary syndrome	0.00466	0.00946	CcSEcCtD
Oxycodone—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00463	0.00941	CcSEcCtD
Oxycodone—Chest pain—Metformin—polycystic ovary syndrome	0.00449	0.00911	CcSEcCtD
Oxycodone—Myalgia—Metformin—polycystic ovary syndrome	0.00449	0.00911	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00446	0.00905	CcSEcCtD
Oxycodone—Discomfort—Metformin—polycystic ovary syndrome	0.00444	0.009	CcSEcCtD
Oxycodone—Oedema—Metformin—polycystic ovary syndrome	0.0043	0.00874	CcSEcCtD
Oxycodone—Infection—Metformin—polycystic ovary syndrome	0.00428	0.00868	CcSEcCtD
Oxycodone—Shock—Metformin—polycystic ovary syndrome	0.00423	0.00859	CcSEcCtD
Oxycodone—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00422	0.00857	CcSEcCtD
Oxycodone—Skin disorder—Metformin—polycystic ovary syndrome	0.00418	0.00848	CcSEcCtD
Oxycodone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00416	0.00844	CcSEcCtD
Oxycodone—Anorexia—Metformin—polycystic ovary syndrome	0.0041	0.00833	CcSEcCtD
Oxycodone—Hypotension—Metformin—polycystic ovary syndrome	0.00402	0.00816	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00392	0.00796	CcSEcCtD
Oxycodone—Paraesthesia—Metformin—polycystic ovary syndrome	0.00386	0.00784	CcSEcCtD
Oxycodone—Dyspnoea—Metformin—polycystic ovary syndrome	0.00384	0.00779	CcSEcCtD
Oxycodone—Somnolence—Metformin—polycystic ovary syndrome	0.00383	0.00777	CcSEcCtD
Oxycodone—Dyspepsia—Metformin—polycystic ovary syndrome	0.00379	0.00769	CcSEcCtD
Oxycodone—Decreased appetite—Metformin—polycystic ovary syndrome	0.00374	0.00759	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00372	0.00754	CcSEcCtD
Oxycodone—Fatigue—Metformin—polycystic ovary syndrome	0.00371	0.00753	CcSEcCtD
Oxycodone—Constipation—Metformin—polycystic ovary syndrome	0.00368	0.00747	CcSEcCtD
Oxycodone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00355	0.0072	CcSEcCtD
Oxycodone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00352	0.00714	CcSEcCtD
Oxycodone—Urticaria—Metformin—polycystic ovary syndrome	0.00342	0.00694	CcSEcCtD
Oxycodone—Abdominal pain—Metformin—polycystic ovary syndrome	0.0034	0.00691	CcSEcCtD
Oxycodone—Asthenia—Metformin—polycystic ovary syndrome	0.00309	0.00627	CcSEcCtD
Oxycodone—Pruritus—Metformin—polycystic ovary syndrome	0.00304	0.00618	CcSEcCtD
Oxycodone—Diarrhoea—Metformin—polycystic ovary syndrome	0.00294	0.00598	CcSEcCtD
Oxycodone—Dizziness—Metformin—polycystic ovary syndrome	0.00285	0.00578	CcSEcCtD
Oxycodone—Vomiting—Metformin—polycystic ovary syndrome	0.00274	0.00555	CcSEcCtD
Oxycodone—Rash—Metformin—polycystic ovary syndrome	0.00271	0.00551	CcSEcCtD
Oxycodone—Dermatitis—Metformin—polycystic ovary syndrome	0.00271	0.0055	CcSEcCtD
Oxycodone—Headache—Metformin—polycystic ovary syndrome	0.0027	0.00547	CcSEcCtD
Oxycodone—Nausea—Metformin—polycystic ovary syndrome	0.00256	0.00519	CcSEcCtD
Oxycodone—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000279	0.00055	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000279	0.00055	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000279	0.000549	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000278	0.000548	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000275	0.000542	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000274	0.000541	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000274	0.00054	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000271	0.000535	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FST—polycystic ovary syndrome	0.000267	0.000527	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000266	0.000524	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000266	0.000524	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000264	0.00052	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000261	0.000515	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000261	0.000514	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.000261	0.000514	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000259	0.000511	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000255	0.000503	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000255	0.000502	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000253	0.000499	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000253	0.000499	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000251	0.000494	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000251	0.000494	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000249	0.000492	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000249	0.00049	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000248	0.000489	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000247	0.000487	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000246	0.000486	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000246	0.000486	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000244	0.000482	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000242	0.000477	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000241	0.000476	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000239	0.00047	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000238	0.00047	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000234	0.000461	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000233	0.00046	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000233	0.00046	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000232	0.000458	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000232	0.000457	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000229	0.000452	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000228	0.00045	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000227	0.000448	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000227	0.000447	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000226	0.000445	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000225	0.000443	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000224	0.000441	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000223	0.00044	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000222	0.000437	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000222	0.000437	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00022	0.000434	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000217	0.000427	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000215	0.000425	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000215	0.000423	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000213	0.000421	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000212	0.000418	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000211	0.000417	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000211	0.000416	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000209	0.000412	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000209	0.000411	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000208	0.00041	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000207	0.000407	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000204	0.000402	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000204	0.000402	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000201	0.000396	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.0002	0.000394	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000198	0.000391	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000198	0.000391	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000197	0.000389	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000197	0.000388	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000196	0.000387	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000196	0.000387	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000194	0.000382	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000192	0.000378	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.000191	0.000377	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00019	0.000375	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000189	0.000373	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000189	0.000373	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000188	0.000371	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000187	0.000369	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000187	0.000369	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000185	0.000365	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	0.000184	0.000363	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000183	0.00036	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000182	0.000358	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.00018	0.000354	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000179	0.000353	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000179	0.000353	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	0.000177	0.000349	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000177	0.000348	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000175	0.000345	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000173	0.000341	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000172	0.000339	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000172	0.000339	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000172	0.000339	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000171	0.000338	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000169	0.000333	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000166	0.000328	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000166	0.000327	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000165	0.000326	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000165	0.000325	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000164	0.000324	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000164	0.000323	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000164	0.000323	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	0.000164	0.000323	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000163	0.000321	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000163	0.00032	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000161	0.000317	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00016	0.000316	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.00016	0.000316	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000159	0.000314	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000158	0.000312	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000158	0.00031	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000157	0.000309	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000155	0.000306	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000152	0.000301	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000152	0.0003	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000152	0.000299	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000151	0.000297	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000151	0.000297	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.00015	0.000296	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00015	0.000296	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000146	0.000287	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000146	0.000287	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000145	0.000285	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000144	0.000283	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000143	0.000281	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000143	0.000281	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000141	0.000278	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TH—polycystic ovary syndrome	0.000141	0.000277	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00014	0.000276	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000139	0.000274	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	0.000138	0.000273	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000137	0.00027	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000135	0.000267	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000135	0.000266	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000134	0.000264	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	0.000133	0.000263	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000132	0.00026	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00013	0.000256	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00013	0.000256	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000129	0.000254	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000128	0.000253	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	0.000128	0.000252	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000128	0.000252	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000127	0.000251	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000127	0.00025	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000126	0.000249	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000126	0.000248	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000124	0.000244	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000122	0.000241	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000121	0.000238	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00012	0.000237	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000119	0.000235	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000118	0.000233	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000118	0.000232	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000117	0.00023	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	0.000115	0.000226	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000114	0.000224	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000112	0.00022	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.00011	0.000217	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	0.000109	0.000216	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000109	0.000214	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000106	0.00021	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000106	0.000209	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000105	0.000208	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000104	0.000206	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000104	0.000204	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000104	0.000204	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000103	0.000203	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TH—polycystic ovary syndrome	0.000102	0.0002	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000102	0.0002	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000101	0.0002	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000101	0.000199	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	9.89e-05	0.000195	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	9.83e-05	0.000194	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.82e-05	0.000194	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.76e-05	0.000192	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.75e-05	0.000192	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	9.67e-05	0.000191	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	9.48e-05	0.000187	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	9.3e-05	0.000183	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.27e-05	0.000183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.24e-05	0.000182	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	9.1e-05	0.000179	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	8.99e-05	0.000177	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.94e-05	0.000176	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	8.9e-05	0.000175	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	8.85e-05	0.000174	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.76e-05	0.000173	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	8.75e-05	0.000173	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.56e-05	0.000169	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.55e-05	0.000169	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	8.49e-05	0.000167	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	8.36e-05	0.000165	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.35e-05	0.000165	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	8.3e-05	0.000164	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.13e-05	0.00016	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	7.91e-05	0.000156	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	7.84e-05	0.000155	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.81e-05	0.000154	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	7.73e-05	0.000152	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—INS—polycystic ovary syndrome	7.69e-05	0.000152	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.62e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	7.52e-05	0.000148	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	7.5e-05	0.000148	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	7.48e-05	0.000147	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.46e-05	0.000147	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.45e-05	0.000147	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.23e-05	0.000143	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	7.23e-05	0.000143	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.23e-05	0.000142	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.21e-05	0.000142	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	7.04e-05	0.000139	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	6.99e-05	0.000138	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.87e-05	0.000135	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.64e-05	0.000131	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	6.62e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.54e-05	0.000129	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.43e-05	0.000127	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.38e-05	0.000126	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.2e-05	0.000122	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.95e-05	0.000117	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.9e-05	0.000116	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.88e-05	0.000116	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	5.67e-05	0.000112	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.62e-05	0.000111	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	5.59e-05	0.00011	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.59e-05	0.00011	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—INS—polycystic ovary syndrome	5.56e-05	0.00011	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.55e-05	0.000109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.53e-05	0.000109	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.47e-05	0.000108	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.33e-05	0.000105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.97e-05	9.8e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.73e-05	9.32e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.72e-05	9.31e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.6e-05	9.07e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	4.41e-05	8.69e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.33e-05	8.53e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.03e-05	7.95e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.98e-05	7.84e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.95e-05	7.79e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	3.87e-05	7.62e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.86e-05	7.61e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.68e-05	7.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.49e-05	6.87e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.27e-05	6.44e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.25e-05	6.41e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.64e-05	5.19e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.6e-05	5.12e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.58e-05	5.1e-05	CbGpPWpGaD
